“Risk of Anaphylaxis and Conjunctivitis With Tralokinumab in Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S63, https://doi.org/10.25251/skin.2.supp.63.